These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 3589702)

  • 21. Therapy of leukemia, Hodgkin's disease and allied disorders.
    COOLEY RN
    Md State Med J; 1954 Feb; 3(2):68-73. PubMed ID: 13132082
    [No Abstract]   [Full Text] [Related]  

  • 22. [Therapy with alpha-interferon in non-Hodgkin's lymphoma with a low grade of malignancy (correct title supplied from Table of Contents)].
    Chisesi T
    Haematologica; 1990; 75 Suppl 4():72-7. PubMed ID: 2074057
    [No Abstract]   [Full Text] [Related]  

  • 23. Autografting followed by nonmyeloablative immunosuppressive chemotherapy and allogeneic peripheral-blood hematopoietic stem-cell transplantation as treatment of resistant Hodgkin's disease and non-Hodgkin's lymphoma.
    Carella AM; Cavaliere M; Lerma E; Ferrara R; Tedeschi L; Romanelli A; Vinci M; Pinotti G; Lambelet P; Loni C; Verdiani S; De Stefano F; Valbonesi M; Corsetti MT
    J Clin Oncol; 2000 Dec; 18(23):3918-24. PubMed ID: 11099321
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High dose alpha-2-recombinant interferon in the treatment of malignant lymphoproliferative diseases. A pilot study.
    Opat P; Drbal J; Vyzula R
    Neoplasma; 1989; 36(4):489-94. PubMed ID: 2770934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.
    Seropian S; Nadkarni R; Jillella AP; Salloum E; Burtness B; Hu GL; Zelterman D; Cooper DL
    Bone Marrow Transplant; 1999 Mar; 23(6):599-605. PubMed ID: 10217191
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High-dose therapy followed by autologous peripheral-blood stem-cell transplantation for patients with Hodgkin's disease and non-Hodgkin's lymphoma using unprimed and granulocyte colony-stimulating factor-mobilized peripheral-blood stem cells.
    Nademanee A; Sniecinski I; Schmidt GM; Dagis AC; O'Donnell MR; Snyder DS; Parker PM; Stein AS; Smith EP; Molina A
    J Clin Oncol; 1994 Oct; 12(10):2176-86. PubMed ID: 7523609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?
    Josting A; Reiser M; Rueffer U; Salzberger B; Diehl V; Engert A
    J Clin Oncol; 2000 Jan; 18(2):332-9. PubMed ID: 10637247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of mobilized CD34-positive peripheral blood progenitor cells in patients with Hodgkin's disease, non-Hodgkin's lymphoma, and cancer of the testis.
    Zeller W; Gutensohn K; Stockschläder M; Dierlamm J; Kröger N; Koehne G; Hummel K; Kabisch H; Weh HJ; Kühnl P; Hossfeld DK; Zander AR
    Bone Marrow Transplant; 1996 May; 17(5):709-13. PubMed ID: 8733686
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of the resistant stages of Hodgkin's disease and lymphoblastic diseases.
    HOCHMAN A; ICKOWICZ M
    Br J Radiol; 1954 Aug; 27(320):467-9. PubMed ID: 13182191
    [No Abstract]   [Full Text] [Related]  

  • 30. Invasive fungal infections in lymphoma patients receiving immunotherapy following autologous bone marrow transplantation (ABMT).
    Toren A; Or R; Ackerstein A; Nagler A
    Bone Marrow Transplant; 1997 Jul; 20(1):67-9. PubMed ID: 9232260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study.
    Wheeler C; Antin JH; Churchill WH; Come SE; Smith BR; Bubley GJ; Rosenthal DS; Rappaport JM; Ault KA; Schnipper LE
    J Clin Oncol; 1990 Apr; 8(4):648-56. PubMed ID: 2313334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of treatment response in patients with lymphoma using [18F]FDG-PET: differences between non-Hodgkin's lymphoma and Hodgkin's disease.
    Spaepen K; Mortelmans L
    Q J Nucl Med; 2001 Sep; 45(3):269-73. PubMed ID: 11788819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hodgkin's disease and non-Hodgkin's lymphomas.
    Fuller LM; Hagemeister FB; Velasquez WS; Sullivan MP
    Compr Ther; 1989 Aug; 15(8):3-11. PubMed ID: 2670408
    [No Abstract]   [Full Text] [Related]  

  • 35. Ongoing studies on non-Hodgkin's lymphomas (NHL) within the EORTC lymphoma group.
    Tirelli U
    Leukemia; 1991; 5 Suppl 1():105-6. PubMed ID: 1890859
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha interferon treatment of low-grade B-cell non-Hodgkin's lymphomas, cutaneous T-cell lymphomas, and chronic lymphocytic leukemia.
    Foon KA; Roth MS; Bunn PA
    Semin Oncol; 1986 Sep; 13(3 Suppl 2):35-42. PubMed ID: 3532334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of the adhesion molecules CD49d and CD49e on G-CSF-mobilized CD34+ cells of patients with solid tumors or non-Hodgkin's and Hodgkin's lymphoma and of healthy donors is inversely correlated with the amount of mobilized CD34+ cells.
    Zeller W; Kröger N; Berger J; Krueger W; Dierlamm J; Stockschläder M; Gutensohn K; Hossfeld DK; Zander AR
    J Hematother Stem Cell Res; 1999 Oct; 8(5):539-46. PubMed ID: 10791904
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Current general principles of the treatment of Hodgkin's disease, lymphosarcoma and reticulosarcoma].
    Bernard J
    Rev Prat; 1966 Mar; 16(7):871-9. PubMed ID: 5324749
    [No Abstract]   [Full Text] [Related]  

  • 39. Clinical trials referral resource. Non-Hodgkin's lymphoma.
    Cheson BD
    Oncology (Williston Park); 1989 Oct; 3(10):37-40, 45-50. PubMed ID: 2640585
    [No Abstract]   [Full Text] [Related]  

  • 40. Randomized trial of peripheral blood progenitor cell vs bone marrow as hematopoietic support for high-dose chemotherapy in patients with non-Hodgkin's lymphoma and Hodgkin's disease: a clinical and molecular analysis.
    Kanteti R; Miller K; McCann J; Roitman D; Morelli J; Hurley C; Berkman E; Schenkein D
    Bone Marrow Transplant; 1999 Sep; 24(5):473-81. PubMed ID: 10482930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.